Consistent with a potential role in cancer, SMARCD3 was highly expressed in end-stage primary tumors from KPf/fC mice, an aggressive model of pancreatic cancer driven by p53 deletion24 (Fig. 1e). Here, TP53 is linked to pancreatic neoplasm.